Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
NCT01210209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2021-05-19
Summary
RATIONALE: Studying samples of blood in the laboratory from patients with cancer and their relatives may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at blood samples collected from patients with Ewing sarcoma and their relatives.
Conditions
- Sarcoma
Interventions
- OTHER
-
genome-wide association study
Sponsors & Collaborators
-
Institut Curie
lead OTHER
Principal Investigators
-
Olivier Delattre, MD · Institut Curie
Eligibility
- Min Age
- 0 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-07
- Primary Completion
- 2019-07-31
- Completion
- 2019-07-31
Countries
- France
Study Locations
More Related Trials
-
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
NCT05100368 ·Status: COMPLETED
-
Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
NCT00048984 ·Status: COMPLETED
-
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
NCT02789384 ·Status: RECRUITING ·Phase: NA
-
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
NCT00579930 ·Status: COMPLETED
-
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438 ·Status: COMPLETED
-
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
NCT04955808 ·Status: SUSPENDED
-
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00758056 ·Status: UNKNOWN
-
Genetic Investigation of Cancer Predisposition
NCT04620278 ·Status: NOT_YET_RECRUITING
-
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
NCT01802125 ·Status: COMPLETED
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
NCT00339898 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
NCT01585376 ·Status: COMPLETED
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171 ·Status: COMPLETED
-
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
NCT06875700 ·Status: RECRUITING
-
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735 ·Status: UNKNOWN ·Phase: NA
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia
NCT01079507 ·Status: UNKNOWN
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
NCT01807143 ·Status: COMPLETED
-
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
NCT01567046 ·Status: COMPLETED
-
Quantitative Imaging Biomarkers for Sarcoma
NCT02579980 ·Status: COMPLETED ·Phase: NA
-
Markers for Predicting Risk of Breast Cancer in Women of Different Races
NCT02574546 ·Status: WITHDRAWN
-
Genomic Analysis of Families With a History of Discordant Cancers
NCT04860453 ·Status: RECRUITING
-
Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology
NCT02220556 ·Status: COMPLETED ·Phase: NA